<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>429-PRIMIDONE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="PRIMIDONE " rxcui="8691">
<ATC code="N03AA03" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="AFATINIB" rxcui="1430438">
<ATC code="L01XE13" />
</DRUG>
</DRUG2>
<DESCRIPTION>Decrease of the plasma concentrations of the afatinib due to increase of its metabolism by the primidone</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Clinical monitoring during the administration of these together and 1 to 2 weeks after they are stopped. </COMMENT>
</INTERACTION>
</INTERACTIONS>
